Suche
Select region
Close filter

Moses Zonana

Kontakt

+305 569 1014

Moses Zonana draws on his experience in MedTech, digital health, telecom and technology to help clients across a range of industries tackle complex transformation, leadership, and organizational challenges. He is active in Egon Zehnder’s Healthcare and Technology Communications Practices, and he is particularly energized by building resilient, adaptable, cohesive, and purpose-driven teams.

Sustainable organizational success is about people, processes, product, and purpose. I am privileged to work with industry leaders to funnel the right talent to the right leadership roles and contextual purpose to harness the full potential of people.

Before joining the Firm, Moses was an entrepreneur, founding and running several start-ups, including Compliance Meds Technologies, Reliance Meds, TLeMAZ and NetLogistiK.

He earned an MBA from Harvard University and a BA from Rutgers University. Moses is active in Angel Investment Groups and was a member of the Entrepreneurs Organization (South Florida Chapter) for more than 10 years. Outside of work, Moses is an avid squash and tennis player.

Kontakt
E-Mail an Moses Zonana
Alles durchsuchen
Interviews, Artikel und Studien

Weltweite Experten

Maria Basler

Maria Basler

Frankfurt

Maria Basler ist Beraterin im Frankfurter Büro von Egon Zehnder. Sie ist Mitglied in der Financial Services Praxisgruppe und leitet die Private Equity… Mehr erfahren

Hélène Reltgen

Hélène Reltgen

Paris

Hélène Reltgen is a Senior Partner at Egon Zehnder, whom she joined in 1999. She leads the Technology & Communications Practice and founded the… Mehr erfahren

Dominik Schrader

Dominik Schrader

Düsseldorf

Dominik Schrader leitet das Düsseldorfer Büro von Egon Zehnder und ist Mitglied der Praxisgruppe Financial Services. Mehr erfahren

Changing language

Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top